All Blogs

Dec 14, 2018

In what could be regarded as a precursor to a new mode of cancer diagnosis, an artificial intelligence based tool, developed at the Osaka University in Japan, can precisely differentiate between different cancer cells, paving the way for automated determination of appropriate individualized cancer treatments. As a m...

Dec 13, 2018

Lilly remunerates AC Immune USD 81 Million for preclinical Alzheimer’s drug Eli Lilly has remunerated USD 81 million upfront for the global rights to AC Immune’s tau aggregation inhibitors in Alzheimer’s disease. The agreement provides Lilly ownership of a small molecule that has prevented tau aggregation in preclin...

Dec 12, 2018

Chinese scientist - He Jiankui’s extraordinary claim regarding making the first babies — twin girls — with edited genomes astonished the world. Among researchers’ principal concerns are the potential effects of the genetic alterations on the health of girls. He, a genome-editing researcher at the Southern University...

Dec 11, 2018

Axovant tips nelotanserin from small molecule R&D Axovant has stopped nelotanserin development after it missed the primary endpoint in a phase 2 trial in patients with Lewy body dementia. The dull data compelled Axovant to miss the drug and finish its pivot from small molecules to gene therapies. The parent comp...

Dec 10, 2018

Gold nanoparticles may soon turn out to be a Prostate cancer treatment option. Apparently, there are certain risks associated with conventional cancer treatments such as uncontrolled bleeding, fatal blood clots and dangerous reactions to the anaesthetic, among others. To relieve patients from such risks, a new clini...

Dec 07, 2018

The world of cancer cells is bewildering, very difficult in understanding. The behaviour of cancer cells is not only complex but also intriguing. Research has been unfolding mystery after mystery of the complex world of cancer cells, shedding more and more light into the mysterious nature of cancer cells. In a new t...

Dec 06, 2018

Roche signs Icagen in neuro drug discovery deal worth up to USD 274 Million Roche and Icagen have signed a licensing and collaboration deal regarding ion channel modulators for neurological disorders. Icagen receives up to USD 274 million in development and commercial milestones. The duo will work on small molecules...

Dec 05, 2018

[caption id="attachment_3727" align="aligncenter" width="2322"] FDA[/caption]

Dec 05, 2018

Coconut oil and dementia  Presently, we have a lack of evidence in displaying coconut oil playing any role in treating dementia or its symptoms. Albeit, there have been some claims regarding coconut oil that it could be used as a treatment, or even a cure, for Alzheimer's disease. But, currently, there is not e...

Dec 04, 2018

If dementia genes are found, drug discovery can be accelerated in brain disorders The overproduction of a protein called tau has been detected in the neuron degeneration that causes Alzheimer’s and other forms of dementia. But the exact genetic process that causes tau is still a mystery. Scientists of the University...